Extracorporeal Membrane Oxygenation Machine Market to Grow at 4.88% CAGR through 2029F
Increased prevalence of lifestyle diseases and availability of skilled professionals to operate ECMO machines is expected to drive the Global Extracorporeal Membrane Oxygenation Machine Market growth in the forecast period, 2025-2029.
According to
TechSci Research report, “Extracorporeal Membrane Oxygenation Machine Market
– Global Industry Size, Share, Trends, Competition, Forecast &
Opportunities, 2029F”, the Global Extracorporeal Membrane Oxygenation
Machine Market stood at USD
394.21 Million in 2023 and is anticipated to project steady growth in
the forecast period with a CAGR of 4.88%
through 2029. The global Extracorporeal Membrane Oxygenation (ECMO)
machine market is driven by several pivotal factors. One of the key drivers is
the rising incidence of cardiovascular and respiratory diseases, which has
created a higher demand for ECMO machines. The increased
availability of technologically advanced ECMO machines has further fueled the
market growth. These innovative machines offer improved functionality,
efficiency, and patient outcomes. The growing number of ECMO centers
across the globe has contributed to the expansion of the market. These centers
provide specialized care and expertise in the field of ECMO, attracting more
patients and driving the market forward. Overall, these factors collectively
play a significant role in shaping the dynamics of the global ECMO machine
market.
Browse over XX
market data Figures spread through XX Pages and an in-depth TOC on
"Global Extracorporeal Membrane Oxygenation Machine Market”
The global
market for Extracorporeal Membrane Oxygenation (ECMO) machines is experiencing
significant growth driven by an increase in the incidence of cardiopulmonary
diseases and respiratory failures. As the prevalence of these conditions
continues to rise, the demand for life-saving ECMO devices is soaring. The
growth in the market can be attributed to several factors. Technological
advancements in ECMO procedures, such as the development of more efficient
oxygenators and improved circuit designs, have contributed to the increased
adoption of ECMO therapy. These advancements have enabled healthcare
professionals to provide better care and support to patients in critical
conditions.
The
growing awareness among healthcare professionals about the benefits of ECMO and
the higher survival rates observed among patients undergoing ECMO treatment
have fueled the demand for these machines. The remarkable outcomes achieved
through ECMO therapy have prompted healthcare providers to recognize the
significance of incorporating this advanced technology into their treatment
protocols.
The
market for ECMO machines is influenced by the rise in government and private
funding for better healthcare infrastructure. Governments around the world are
increasingly recognizing the importance of investing in advanced medical
technologies like ECMO to improve patient outcomes. This has led to the
establishment of specialized ECMO centers and the procurement of ECMO machines
in various healthcare facilities.
Ongoing research and development activities aimed at making ECMO machines more
compact and efficient have played a crucial role in driving the market growth.
Manufacturers are continuously striving to reduce the size and weight of ECMO
devices while enhancing their functionality and ease of use. These advancements
have not only made ECMO therapy more accessible but also improved patient
comfort and outcomes.
The global
market for ECMO machines is witnessing remarkable growth due to the rising
incidence of cardiopulmonary diseases, technological advancements, increasing
awareness, higher survival rates, funding for healthcare infrastructure, and
ongoing research and development efforts. With its continuous evolution and
innovation, ECMO is set to revolutionize the treatment of critical respiratory
and cardiac conditions, providing a lifeline to patients in need. The future of
ECMO looks promising as it continues to pave the way for improved patient care
and outcomes.
The Global Extracorporeal
Membrane Oxygenation Machine Market is segmented into component type, modality,
patient type, application, regional distribution, and company.
Based on patient type, adults
currently dominate in terms of usage and market demand. While ECMO can be
utilized across all age groups, including neonates, pediatric, and adult
patients, the adult segment exhibits the highest utilization due to several
factors. Adults constitute a larger proportion of patients requiring ECMO
support compared to neonates and pediatric patients. This is attributed to the
higher prevalence of conditions such as acute respiratory distress syndrome
(ARDS), cardiac failure, and severe respiratory failure among adults. These
conditions often necessitate advanced life support measures like ECMO to
maintain adequate oxygenation and circulation.
ECMO technology
has witnessed significant advancements over the years, particularly in the
development of ECMO circuits and devices tailored for adult patients. These
advancements have resulted in improved safety, efficiency, and ease of use,
making ECMO a viable treatment option for a wider range of adult patients with
complex medical conditions. The rising incidence of severe respiratory
illnesses, such as pneumonia, influenza, and acute respiratory distress
syndrome (ARDS), among adults further drives the demand for ECMO support in
this demographic. As the aging population continues to grow and the prevalence
of chronic diseases increases, the need for ECMO therapy in adults is expected
to rise correspondingly.
Based on region, several factors
contribute to North America's dominance in the global Extracorporeal Membrane
Oxygenation (ECMO) machine market. The region's advanced healthcare
infrastructure facilitates the efficient adoption and utilization of ECMO
technology. With high healthcare expenditure, North America invests extensively
in cutting-edge medical devices and technologies. The presence of leading
medical device manufacturers further enhances the region's dominance in the
ECMO machine market, as these companies possess the expertise and resources to
develop high-quality ECMO machines meeting healthcare providers' and patients'
demands.
North America
experiences a high incidence of cardiovascular and respiratory diseases,
driving the demand for ECMO as a life-saving procedure. The population faces a
significant burden of these diseases, necessitating the availability and
accessibility of ECMO machines for critical care interventions. Robust research
and development initiatives in ECMO technology strengthen North America's
position in the market, fostering continuous advancements driven by
collaborations among academia, healthcare institutions, and industry
stakeholders. The government's support for technology integration in healthcare
creates a favorable environment for the ECMO machine market's growth in North
America. Policies and initiatives aimed at promoting advanced medical
technologies, including ECMO, contribute to market expansion and facilitate
improved patient outcomes. Overall, North America's comprehensive healthcare
ecosystem, coupled with a high disease burden and supportive regulatory
environment, sustains its leadership in the global ECMO machine market.
Major companies
operating in Global Extracorporeal Membrane Oxygenation Machine Market
are:
- Medtronic plc
- Sorin Group
- Terumo Cardiovascular Systems Corporation
- MAQUET Holding B.V. & Co. KG
- Medos Medizintechnik AG
- Nipro Medical Corporation
- MicroPort Scientific Corporation
- XENIOS AG
- LivaNova PLC
- EUROSETS S.r.l.
Download Free Sample Report
Customers can
also request for 10% free customization on this report
“The future of
the Extracorporeal Membrane Oxygenation (ECMO) Machine Market holds significant
promise, buoyed by a convergence of factors that are poised to drive its growth
trajectory. Technological advancements stand at the forefront of this
optimistic outlook, with continuous innovation enhancing the capabilities and
efficiency of ECMO machines. These advancements not only improve the
performance and reliability of ECMO systems but also contribute to enhanced
patient outcomes and safety. The escalating incidence of cardiovascular and
respiratory diseases globally is fueling the demand for advanced medical
interventions such as ECMO. As these conditions continue to pose significant
health challenges and strain healthcare systems, the need for effective treatment
modalities like ECMO becomes increasingly pronounced. ECMO therapy offers a
vital lifeline for patients with severe cardiac or pulmonary dysfunction,
providing temporary support to vital organ systems while allowing for recovery
or transplantation. The expanding adoption of ECMO in intensive care units
(ICUs) across the globe is poised to drive market growth. As healthcare
facilities strive to improve patient care and outcomes, ECMO has emerged as a
valuable tool in the armamentarium of critical care medicine. The development
of portable ECMO machines represents a significant milestone in the evolution
of ECMO technology. These compact and transportable systems offer greater
flexibility and accessibility, allowing for the provision of ECMO therapy in a
wider range of clinical settings, including ambulances and remote healthcare
facilities. This expansion of ECMO's reach is expected to further fuel market
growth and broaden its applications beyond traditional hospital settings.,” said Mr. Karan Chechi,
Research Director, TechSci Research, a research-based management consulting
firm.
“Extracorporeal Membrane Oxygenation Machine Market
- Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Component Type
(Pumps, Oxygenator, Controllers, Cannula, Accessories), By Modality
(Veno-Arterial, Veno-Venous, Arterio-Venous), By Patient Type (Neonates, Pediatric,
Adult), By Application (Respiratory, Cardiac, ECPR), By Region and Competition, 2019-2029F”,
has evaluated the future growth potential of Global Extracorporeal Membrane
Oxygenation Machine Market and provides statistics & information on market
size, structure and future market growth. The report intends to provide
cutting-edge market intelligence and help decision makers take sound investment
decisions. Besides, the report also identifies and analyzes the emerging trends
along with essential drivers, challenges, and opportunities in Global Extracorporeal
Membrane Oxygenation Machine Market.
Contact
TechSci
Research LLC
420
Lexington Avenue, Suite 300,
New York,
United States- 10170
Tel: +1-332-258-6602
Email: [email protected]
Website: www.techsciresearch.com